- Aggressive diagnosis and treatment for posterior urethral valve as an etiology for vesicoureteral reflux or urge incontinence in children
-
Nakai H, Hyuga T, Kawai S, Kubo T, Nakamura S
- KMID: 2379895
- Investig Clin Urol.
- 2017 Jun;58(Suppl 1):S46-S53.
- doi: 10.4111/icu.2017.58.S1.S46
Vesicoureteral reflux (VUR) is one of the most common diseases in pediatric urology and classified into primary and secondary VUR. Although posterior urethral valve (PUV) is well known as a... -
- CITED
-
- Close
- SHARE
-
- Close
- Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer
-
Sakae C, Yamaguchi , Matsumura , Nakai H, Yoshioka Y, Kondoh E, Hamanishi , Abiko K, Koshiyama , Baba T, Kido A, Mandai M, Konishi I
- KMID: 2374259
- J Gynecol Oncol.
- 2016 Nov;27(6):e57.
- doi: 10.3802/jgo.2016.27.e57
OBJECTIVE: To identify suitable diagnostic tools and evaluate the efficacy of sentinel lymph node (SLN) biopsy for inguinal lymph node metastasis in vulvar cancer. METHODS: Data from 41 patients with vulvar... -
- CITED
-
- Close
- SHARE
-
- Close
- Adult granulosa cell tumors of the ovary: a retrospective study of 30 cases with respect to the expression of steroid synthesis enzymes
-
Kitamura S, Abiko K, Matsumura , Nakai H, Akimoto Y, Tanimoto H, Konishi I
- KMID: 2413425
- J Gynecol Oncol.
- 2017 Jul;28(4):e31.
- doi: 10.3802/jgo.2017.28.e31
OBJECTIVE: Some, but not all, granulosa cell tumors are characterized by estrogen production. This study was designed to determine whether there are clinical or pathological variations in granulosa cell tumors... -
- CITED
-
- Close
- SHARE
-
- Close
- Quality indicators for cervical cancer care in Japan
-
Watanabe T, Mikami M, Katabuchi , Kato S, Kaneuchi M, Takahashi , Nakai H, Nagase S, Niikura H, Mandai M, Hirashima , Yanai H, Yamagami W, Kamitani S, Higashi T
- KMID: 2431230
- J Gynecol Oncol.
- 2018 Nov;29(6):e83.
- doi: 10.3802/jgo.2018.29.e83
OBJECTIVE: We aimed to propose a set of quality indicators (QIs) based on the clinical guidelines for cervical cancer treatment published by The Japan Society of Gynecologic Oncology, and to... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer
-
Takehara K, Matsumoto T, Hamanishi J, Hasegawa K, Matsuura M, Miura K, Nagao S, Nakai H, Tanaka N, Tokunaga H, Ushijima K, Watari H, Yokoyama Y, Kase Y, Sumino S, Suri A, Itamochi H, Takeshima N
- KMID: 2526362
- J Gynecol Oncol.
- 2021 Mar;32(2):e21.
- doi: 10.3802/jgo.2021.32.e21
Objective: The primary objective of this study was to evaluate the safety of niraparib 300 mg/day in Japanese patients with platinum-sensitive, relapsed ovarian cancer in a maintenance setting. Methods: Phase 2,... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer
-
Okamoto A, Kondo E, Nakamura T, Yanagida S, Hamanishi J, Harano K, Hasegawa K, Hirasawa T, Hori K, Komiyama S, Matsuura M, Nakai H, Nakamura H, Sakata J, Tabata T, Takehara K, Takekuma M, Yokoyama Y, Kase Y, Sumino S, Soeda J, Suri A, Aoki D, Sugiyama T
- KMID: 2526354
- J Gynecol Oncol.
- 2021 Mar;32(2):e16.
- doi: 10.3802/jgo.2021.32.e16
Objective: To evaluate the efficacy and safety of niraparib in Japanese women with heavily pretreated ovarian cancer. Methods: This Phase 2 open-label, single-arm study enrolled Japanese women with homologous recombination deficiency-positive... -
- CITED
-
- Close
- SHARE
-
- Close
